Literature DB >> 12449047

Studying drugs in human milk: time to unify the approach.

Evan J Begg1, Stephen B Duffull, L Peter Hackett, Kenneth F Ilett.   

Abstract

The trend globally for mothers to breastfeed has highlighted the need for information on drug transfer into breast milk and the extent to which the suckling neonate may be exposed and affected. This review discusses robust study methodologies that will yield high-quality information on all aspects of this process. Methods for assessing drug transfer into breast milk are examined. The place of the milk/plasma ratio, the amount of drug in breast milk, and the volume of milk produced are discussed in the context of their utility in estimating both absolute and relative infant dose. The measurement of plasma drug concentrations and pharmacodynamic effects in the breastfed infant exposed to drugs are identified as important factors that can assist in deciding whether drug present in breast milk is a significant risk for the nursing infant.

Entities:  

Mesh:

Year:  2002        PMID: 12449047     DOI: 10.1177/089033402237904

Source DB:  PubMed          Journal:  J Hum Lact        ISSN: 0890-3344            Impact factor:   2.219


  25 in total

1.  Transfer of the antidepressant mirtazapine into breast milk.

Authors:  J H Kristensen; Kenneth F Ilett; Jonathan Rampono; Rolland Kohan; L Peter Hackett
Journal:  Br J Clin Pharmacol       Date:  2006-09-13       Impact factor: 4.335

2.  Transfer of methylamphetamine and amphetamine into breast milk following recreational use of methylamphetamine.

Authors:  Anne Bartu; Leon J Dusci; Kenneth F Ilett
Journal:  Br J Clin Pharmacol       Date:  2009-04       Impact factor: 4.335

3.  Transfer of escitalopram and its metabolite demethylescitalopram into breastmilk.

Authors:  Jonathan Rampono; L Peter Hackett; Judith H Kristensen; Rolland Kohan; Madhu Page-Sharp; Kenneth F Ilett
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

Review 4.  The quality of lactation studies including antipsychotics.

Authors:  Hazel Hummels; Daphne Bertholee; Douwe van der Meer; Jan Pieter Smit; Bob Wilffert; Peter Ter Horst
Journal:  Eur J Clin Pharmacol       Date:  2016-08-24       Impact factor: 2.953

Review 5.  Drugs in Lactation.

Authors:  Philip O Anderson
Journal:  Pharm Res       Date:  2018-02-06       Impact factor: 4.200

6.  Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs.

Authors:  Sharon J Gardiner; Richard B Gearry; Rebecca L Roberts; Mei Zhang; Murray L Barclay; Evan J Begg
Journal:  Br J Clin Pharmacol       Date:  2006-10       Impact factor: 4.335

7.  Pharmacokinetics of amlodipine besylate at delivery and during lactation.

Authors:  Jamie L Morgan; Benjamin K Kogutt; Claudia Meek; Elizabeth K Stehel; Donald D McIntire; Jeanne S Sheffield; Scott W Roberts
Journal:  Pregnancy Hypertens       Date:  2018-01-04       Impact factor: 2.899

8.  Pseudoephedrine: effects on milk production in women and estimation of infant exposure via breastmilk.

Authors:  Khalidah Aljazaf; Thomas W Hale; Kenneth F Ilett; Peter E Hartmann; Leon R Mitoulas; Judith H Kristensen; L Peter Hackett
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

Review 9.  Effect of pregnancy on the pharmacokinetics of antihypertensive drugs.

Authors:  Gail D Anderson; Darcy B Carr
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

10.  Transfer of isoniazid from circulation to breast milk in lactating women on chronic therapy for tuberculosis.

Authors:  Neera Singh; Anil Golani; Zarine Patel; Anurupa Maitra
Journal:  Br J Clin Pharmacol       Date:  2007-12-17       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.